CCTG Senior Investigator Chris O’Callaghan is named the 2022 NET Research Grant Recipient
Published:Category: News
Canadian Neuroendocrine Tumour Society (CNETS) 2022 Research Grant Award to support Canadian participation in STOPNET international trial. STOPNET is a Randomized Study of Cessation of Somatostatin Analogues after Peptide Receptor Radionuclide Therapy in Mid-Gut Neuroendocrine Tumours.
Read More2023 CCTG Annual Spring Meeting
Published:Category: Group updates
Update: Non-funded invitations will be sent and request an invitation portal opens at the beginning of March.
Meeting Invitations
If you are planning meetings and/or attending the Spring Meeting be sure to read your invitation carefully so you are clear on the the funding support associated with your invitation.
Read MoreAward nominations due this week!
Published:Category: Group updates
Founder's Award: Dr. Joseph Pater Excellence in Clinical Trials Research
The Founder's Award is presented annually to an investigator whose leadership and body of work has contributed to significant advances in the understanding, diagnosis, treatment, cure, and prevention of cancer. This award honours an Investigator whose excellence in clinical trials research has provided techniques, information or concepts that will direct the future of the oncology research community and the Canadian Cancer Trials Group.
CCTG MA41 Breast Cancer Study opens in Canada
Published:Category: News
The purpose of this study is to test whether a new drug regimen will reduce the chances of side effects but be just as effective as the usual treatment for HER2-positive, ER-negative and node negative breast cancer. HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), this protein promotes the growth of cancer cells. Read More
Publications: Statistical Review
Published:Category: Publications
Bootstrap adjusted predictive classification for identification of subgroups with differential treatment effects under generalized linear models
Na L, Yanglei S, Lin CD, Dongsheng T. Bootstrap adjusted predictive classification for identification of subgroups with differential treatment effects under generalized linear models (ONLINE).
Read MorePublication IND227
Published:Category: Publications
Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171)
Read MoreCentral Office Closures – Limited Operations Friday February 17th & Closure Monday February 20th
Published:Category: Group updates
Please note that in the lead up to Family Day, CCTG Central Office will have limited coverage of critical activities only on Friday February 17th and will be closed Monday
Read MoreThe 2023 CCTG Annual Spring Meeting of Participants
Published:Category: Group updates
The CCTG Annual Spring Meeting of Participants will be held Friday, April 28 to Sunday, April 30 at the Chelsea Hotel, Toronto. As we close in on the meeting, we will continue to keep you updated on all of the deadlines, so stay tuned!